97 related articles for article (PubMed ID: 24524120)
21. Latent class analysis of diagnostic tests for adenovirus, Bordetella pertussis and influenza virus infections in German adults with longer lasting coughs.
Sobotzki C; Riffelmann M; Kennerknecht N; Hülsse C; Littmann M; White A; Von Kries R; Wirsing VON König CH
Epidemiol Infect; 2016 Mar; 144(4):840-6. PubMed ID: 26380914
[TBL] [Abstract][Full Text] [Related]
22. Influenza viruses with reduced sensitivity to the neuraminidase inhibitor drugs in untreated young children.
Hurt AC; Barr IG
Commun Dis Intell Q Rep; 2008 Mar; 32(1):57-62. PubMed ID: 18522305
[TBL] [Abstract][Full Text] [Related]
23. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
Mohr PG; Geyer H; McKimm-Breschkin JL
Antiviral Res; 2011 Jul; 91(1):20-2. PubMed ID: 21549758
[TBL] [Abstract][Full Text] [Related]
24. [Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China].
Huang W; Li X; Tan M; Wei H; Cheng Y; Guo J; Wang Z; Xiao N; Wang D; Shu Y
Bing Du Xue Bao; 2015 Mar; 31(2):152-6. PubMed ID: 26164940
[TBL] [Abstract][Full Text] [Related]
25. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
[TBL] [Abstract][Full Text] [Related]
26. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
27. Standardization of denaturing gradient gel electrophoresis (DGGE) for discrimination of Victoria and Yamagata lineages of influenza B.
Resende PC; Siqueira MM; Born PS; Motta FC
J Virol Methods; 2012 Jan; 179(1):212-6. PubMed ID: 22079619
[TBL] [Abstract][Full Text] [Related]
28. The potential impact of neuraminidase inhibitor resistant influenza.
Lackenby A; Thompson CI; Democratis J
Curr Opin Infect Dis; 2008 Dec; 21(6):626-38. PubMed ID: 18978531
[TBL] [Abstract][Full Text] [Related]
29. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
[TBL] [Abstract][Full Text] [Related]
30. [Present data on influenza virus isolated from ducks and chickens, and influenza virus C. Anti-influenza drugs].
Fernández del Campo JA
An R Acad Nac Med (Madr); 2004; 121(2):305-30. PubMed ID: 15563121
[TBL] [Abstract][Full Text] [Related]
31. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
[TBL] [Abstract][Full Text] [Related]
32. Summary analysis of 2014 survey of National Influenza Centres in the WHO Global Influenza Surveillance and Response System.
Wkly Epidemiol Rec; 2014 Aug; 89(34):369-76. PubMed ID: 25147890
[No Abstract] [Full Text] [Related]
33. [Consecutive infections by different types and subtypes of influenza virus in the same epidemic season].
Reina J; Plasencia V; Ferres F
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):257-8. PubMed ID: 19664856
[No Abstract] [Full Text] [Related]
34. Hemagglutinin and neuraminidase genes of influenza B viruses circulating in Riyadh, Saudi Arabia during 2010-2011: evolution and sequence analysis.
Ali G; Amer HM; Almajhdi FN
J Med Virol; 2014 Jun; 86(6):1003-16. PubMed ID: 24150926
[TBL] [Abstract][Full Text] [Related]
35. [Influenza A, B, C viruses].
Matsuzaki Y
Nihon Rinsho; 2010 Jun; 68 Suppl 6():376-9. PubMed ID: 20942083
[No Abstract] [Full Text] [Related]
36. Influenza.
Wkly Epidemiol Rec; 2003 Nov; 78(48):414-6. PubMed ID: 14669457
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study.
van der Vries E; Ip DK; Cowling BJ; Zhang JD; Tong X; Wojtowicz K; Schutten M; Boucher CA
J Infect Dis; 2016 Jan; 213(2):183-90. PubMed ID: 26160744
[TBL] [Abstract][Full Text] [Related]
38. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
Escuret V; Frobert E; Bouscambert-Duchamp M; Sabatier M; Grog I; Valette M; Lina B; Morfin F; Ferraris O
J Clin Virol; 2008 Jan; 41(1):25-8. PubMed ID: 18055253
[TBL] [Abstract][Full Text] [Related]
39. Influenza virus susceptibility and resistance to oseltamivir.
Aoki FY; Boivin G; Roberts N
Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
[TBL] [Abstract][Full Text] [Related]
40. Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
Wkly Epidemiol Rec; 2007 Apr; 82(17):149-50. PubMed ID: 17465078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
